Researchers from Atlanta’s Emory University played a key role in the development of molnupiravir, which if approved by federal health officials could serve as a “breakthrough” in fighting COVID.  The drug, originally developed to combat an array of other viruses including influenza, has showed “compelling” results in clinical trials.  George Painter, a professor in the Emory School of Medicine and head of the school’s Drug Innovation Ventures at Emory (DRIVE) program, says that tests show molnupiravir reduces the risk of hospitalization or death from COVID by roughly 50%.  Emory scientists making a breakthrough that could save thousands of lives has their reputation before the whole world RISING…

Login

Lost your password?